Literature DB >> 2754729

Construction of plasmids containing a unique acetylaminofluorene adduct located within a mutation hot spot. A new probe for frameshift mutagenesis.

P Koehl1, D Burnouf, R P Fuchs.   

Abstract

N-2-acetylaminofluorene (AAF), a potent rat liver carcinogen, binds primarily to the C-8 position of guanine residues. In a bacterial forward mutation assay, more than 90% of the mutations induced by -AAF adducts are frameshift mutations located at specific sites: the so-called mutation hot spots. We are particularly interested in a class of -2 frameshift mutations occurring within a specific sequence, the NarI sequence. The NarI site, GGCGCC, contains three guanine residues that are approximately equally reactive toward -AAF substitution. To study further the mechanism by which mutations are induced by -AAF adducts at this site, we designed a new plasmid probe. In this paper we describe the construction and the effectiveness of this probe, pSM14, which provides a simple phenotypic test for detecting frameshift mutations within the NarI site. The construction and the characterization of plasmids with a single -AAF adduct in each of the three positions of the NarI site are also described. The strategy of construction that was used involves the ligation of oligonucleotides containing a single adduct in a NarI site into a gapped-duplex pSM14 plasmid. Plasmids that have successfully integrated the oligonucleotides by ligation at both the 5' and the 3' ends were purified by centrifugation on CsCl gradients. These constructs have been used in single adduct mutation studies.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2754729     DOI: 10.1016/0022-2836(89)90259-3

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  33 in total

1.  Mechanism of DNA polymerase II-mediated frameshift mutagenesis.

Authors:  O J Becherel; R P Fuchs
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-10       Impact factor: 11.205

2.  DNA methylation inhibits transcription of procollagen alpha 2(I) promoters.

Authors:  D K Guenette; J D Ritzenthaler; J Foley; J D Jackson; B D Smith
Journal:  Biochem J       Date:  1992-05-01       Impact factor: 3.857

3.  DNA repair and sequence context affect (1)O(2)-induced mutagenesis in bacteria.

Authors:  L F Agnez-Lima; R L Napolitano; R P Fuchs; P D Mascio; A R Muotri; C F Menck
Journal:  Nucleic Acids Res       Date:  2001-07-01       Impact factor: 16.971

4.  Carcinogen-induced frameshift mutagenesis in repetitive sequences.

Authors:  I B Lambert; R L Napolitano; R P Fuchs
Journal:  Proc Natl Acad Sci U S A       Date:  1992-02-15       Impact factor: 11.205

Review 5.  Biological properties of single chemical-DNA adducts: a twenty year perspective.

Authors:  James C Delaney; John M Essigmann
Journal:  Chem Res Toxicol       Date:  2007-12-12       Impact factor: 3.739

6.  Polymorphism in N-2-acetylaminofluorene induced DNA structure as revealed by DNase I footprinting.

Authors:  X Veaute; R P Fuchs
Journal:  Nucleic Acids Res       Date:  1991-10-25       Impact factor: 16.971

Review 7.  Translesion DNA synthesis and mutagenesis in prokaryotes.

Authors:  Robert P Fuchs; Shingo Fujii
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-12-01       Impact factor: 10.005

8.  SOS factors involved in translesion synthesis.

Authors:  R L Napolitano; I B Lambert; R P Fuchs
Journal:  Proc Natl Acad Sci U S A       Date:  1997-05-27       Impact factor: 11.205

9.  Human and E.coli excinucleases are affected differently by the sequence context of acetylaminofluorene-guanine adduct.

Authors:  D Mu; E Bertrand-Burggraf; J C Huang; R P Fuchs; A Sancar; B P Fuchs
Journal:  Nucleic Acids Res       Date:  1994-11-25       Impact factor: 16.971

10.  Acetylaminofluorene bound to different guanines of the sequence -GGCGCC- is excised with different efficiencies by the UvrABC excision nuclease in a pattern not correlated to the potency of mutation induction.

Authors:  E Seeberg; R P Fuchs
Journal:  Proc Natl Acad Sci U S A       Date:  1990-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.